Antimicrobial resistance (AMR) has become one of the most pressing global health threats, responsible for an estimated 35,000 deaths annually in the United States alone (CDC, 2023). Resistant infections increase hospital stays, raise medical costs, and reduce the effectiveness of life-saving treatments. The misuse and overuse of antibiotics in both healthcare and agriculture have accelerated the spread of resistance, making it harder to treat even common bacterial infections.
Rapid detection of antibiotic resistance markers is critical to guide appropriate treatment and prevent the further spread of resistant strains. YouSeq’s Antibiotic Resistance qPCR test kits enable precise identification of key resistance genes, including mecA (methicillin resistance), blaKPC (carbapenem resistance), and vanA/B (vancomycin resistance).
Our assays deliver highly sensitive and specific results, empowering clinicians to select effective treatments and avoid unnecessary use of broad-spectrum antibiotics. In addition to pathogen-specific resistance detection, our panels are designed for efficient workflows, reducing diagnostic turnaround times in both clinical and research laboratories.
By equipping laboratories with robust molecular tools, YouSeq’s qPCR kits play a crucial role in addressing the global AMR crisis. Our commitment to accuracy and quality ensures laboratories can trust our assays to deliver actionable insights for combating this growing public health threat.
